Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3761699014 | Amlodipine (as amlodipine besylate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3761700010 | Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3761701014 | Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing amlodipine and hydrochlorothiazide and olmesartan medoxomil | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Amlodipine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Olmesartan medoxomil | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing amlodipine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing hydrochlorothiazide in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing amlodipine and olmesartan in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 3 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only amlodipine and hydrochlorothiazide and olmesartan in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 5 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Amlodipine | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Amlodipine besilate | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 40 | false | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Olmesartan medoxomil | true | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 12.5 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Hydrochlorothiazide | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Hydrochlorothiazide | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Olmesartan medoxomil | true | Inferred relationship | Existential restriction modifier | 3 | |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) | Plays role | Diuretic therapeutic role | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets